Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
resTORbio
Biotech
Adicet inks resTORbio reverse merger, plots financing
Adicet Bio has struck a deal to merge with resTORbio, bagging itself a Nasdaq listing to support its pipeline of allogeneic gamma delta CAR-Ts.
Nick Paul Taylor
Apr 30, 2020 8:00am
Nearing phase 3, resTORbio posts new data on infection drug
Oct 16, 2018 8:55am
resTORbio surges on midstage data for aging drug
Jul 25, 2018 9:27am
Chutes & Ladders—Alder poaches Juno executive for CEO
Jun 15, 2018 10:56am
ResTORbio brings on Novartis researcher as clinical VP
Jun 12, 2018 1:53pm
New Year biotech IPO hopefuls gun for $369M
Jan 2, 2018 4:56am
